The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Abseamed

5000 international unit(s) Solution for injection

Medice Arzneimittel Putter GmbHEU/1/07/412/9-10

Main Information

Trade NameAbseamed
Active SubstancesRecombinant human erythropoietin alfa
Strength5000 international unit(s)
Dosage FormSolution for injection
Licence HolderMedice Arzneimittel Putter GmbH
Licence NumberEU/1/07/412/9-10

Group Information

ATC CodeB03XA Other antianemic preparations
B03XA01 erythropoietin

Status

Authorised/WithdrawnAuthorised
Licence Issued28/08/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back